CoChat

Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease

Open access
Nielsen, Jonas B., Rom, Oren, Surakka, Ida, Graham, Sarah E., Zhou, Wei, Roychowdhury, Tanmoy, Fritsche, Lars G., Gagliano Taliun, Sarah A., Sidore, Carlo, Liu, Yuhao, Gabrielsen, Maiken E., Skogholt, Anne Heidi, Wolford, Brooke, Overton, William, Zhao, Ying, Chen, Jin, Zhang, He, Hornsby, Whitney E., Acheampong, Akua, Grooms, Austen, Schaefer, Amanda, Zajac, Gregory J. M., Villacorta, Luis, Zhang, Jifeng, Brumpton, Ben, Løset, Mari, Rai, Vivek, Lundegaard, Pia R., Olesen, Morten S., Taylor, Kent D., Palmer, Nicholette D., Chen, Yii-Der, Choi, Seung H., Lubitz, Steven A., Ellinor, Patrick T., Barnes, Kathleen C., Daya, Michelle, Rafaels, Nicholas, Weiss, Scott T., Lasky-Su, Jessica, Tracy, Russell P., Vasan, Ramachandran S., Cupples, L. Adrienne, Mathias, Rasika A., Yanek, Lisa R., Becker, Lewis C., Peyser, Patricia A., Bielak, Lawrence F., Smith, Jennifer A., Aslibekyan, Stella, Hidalgo, Bertha A., Arnett, Donna K., Irvin, Marguerite R., Wilson, James G., Musani, Solomon K., Correa, Adolfo, Rich, Stephen S., Guo, Xiuqing, Rotter, Jerome I., Konkle, Barbara A., Johnsen, Jill M., Ashley-Koch, Allison E., Telen, Marilyn J., Sheehan, Vivien A., Blangero, John, Curran, Joanne E., Peralta, Juan M., Montgomery, Courtney, Sheu, Wayne H-H, Chung, Ren-Hua, Schwander, Karen, Nouraie, Seyed M., Gordeuk, Victor R., Zhang, Yingze, Kooperberg, Charles, Reiner, Alexander P., Jackson, Rebecca D., Bleecker, Eugene R., Meyers, Deborah A., Li, Xingnan, Das, Sayantan, Yu, Ketian, LeFaive, Jonathon, Smith, Albert, Blackwell, Tom, Taliun, Daniel, Zollner, Sebastian, Forer, Lukas, Schoenherr, Sebastian, Fuchsberger, Christian, Pandit, Anita, Zawistowski, Matthew, Kheterpal, Sachin, Brummett, Chad M., Natarajan, Pradeep, Schlessinger, David, Lee, Seunggeun, Kang, Hyun Min, Cucca, Francesco, Holmen, Oddgeir L., Åsvold, Bjørn O., Boehnke, Michael, Kathiresan, Sekar, Abecasis, Goncalo R., Chen, Y. Eugene, Willer, Cristen J., Hveem, Kristian · 2020 · Nature Communications
Cited by 71

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Pharmaceutical drugs targeting dyslipidemia and cardiovascular disease (CVD) may increase the risk of fatty liver disease and other metabolic disorders. To identify potential novel CVD drug targets without these adverse effects, we perform genome-wide analyses of participants in the HUNT Study in Norway (n = 69,479) to search for protein-altering variants with beneficial impact on quantitative blood traits related to cardiovascular disease, but without detrimental impact on liver function. We identify 76 (11 previously unreported) presumed causal protein-altering variants associated with one or more CVD- or liver-related blood traits. Nine of the variants are predicted to result in loss-of-function of the protein. This includes ZNF529:p.K405X, which is associated with decreased low-density-lipoprotein (LDL) cholesterol (P = 1.3 × 10−8) without being associated with liver enzymes or non-fasting blood glucose. Silencing of ZNF529 in human hepatoma cells results in upregulation of LDL receptor and increased LDL uptake in the cells. This suggests that inhibition of ZNF529 or its gene product should be prioritized as a novel candidate drug target for treating dyslipidemia and associated CVD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-020-20086-3

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 40

  1. Lund, E. G., Menke, J. G. & Sparrow, C. P. Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23, 1169–1177 (2003). · DOI · Paper page
  2. Newman Connie, B. et al. Statin safety and associated adverse events: a scientific statement from the American Heart Association. Arterioscler. Thromb. Vasc. Biol. 39, e38–e81 (2019).
  3. Zhou, W. et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat. Genet. 50, 1335–1341 (2018). · DOI · Paper page
  4. Pilia, G. et al. Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet. 2, e132 (2006). · DOI · Paper page
  5. Trecartin, R. F. et al. beta zero thalassemia in Sardinia is caused by a nonsense mutation. J. Clin. Invest. 68, 1012–1017 (1981). · DOI · Paper page
  6. Green, R. C. et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet. Med. J. Am. Coll. Med. Genet. 15, 565–574 (2013).
  7. Liu, D. J. et al. Exome-wide association study of plasma lipids in >300,000 individuals. Nat. Genet. 49, 1758–1766 (2017). · DOI · Paper page
  8. Klarin, D. et al. Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program. Nat. Genet. 50, 1514–1523 (2018). · DOI · Paper page
  9. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet Lond. Engl. 344, 1383–1389 (1994). · DOI · Paper page
  10. Nielson, C. M. et al. Rare coding variants in ALPL are associated with low serum alkaline phosphatase and low bone mineral density. J. Bone Miner. Res. J. Am. Soc. Bone Miner. Res. 27, 93–103 (2012). · DOI
  11. Chambers, J. C. et al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat. Genet. 43, 1131–1138 (2011). · DOI · Paper page
  12. Zhou, W. et al. Scalable generalized linear mixed model for region-based association tests in large biobanks and cohorts. Nat. Genet. 52, 634–639 (2020). · DOI · Paper page
  13. Denny, J. C. et al. Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat. Biotechnol. 31, 1102–1110 (2013). · DOI · Paper page
  14. Wu, P. et al. Mapping ICD-10 and ICD-10-CM codes to phecodes: workflow development and initial evaluation. JMIR Med. Inform. 7, e14325 (2019). · DOI · Paper page
  15. Silverman, E. K. & Sandhaus, R. A. Clinical practice. Alpha1-antitrypsin deficiency. N. Engl. J. Med. 360, 2749–2757 (2009). · DOI · Paper page
  16. Fähndrich, S. et al. Cardiovascular risk in patients with alpha-1-antitrypsin deficiency. Respir. Res. 18, 171 (2017). · DOI
  17. Toldo, S. et al. Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury. J. Mol. Cell. Cardiol. 51, 244–251 (2011). · DOI
  18. Zhang, G. et al. Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation. Blood 122, 443–455 (2013). · DOI · Paper page
  19. Rust, R. et al. Nogo-A targeted therapy promotes vascular repair and functional recovery following stroke. Proc. Natl Acad. Sci. USA 116, 14270–14279 (2019). · DOI
  20. Fan, J.-L., Zhang, L. & Bo, X.-H. MiR-126 on mice with coronary artery disease by targeting S1PR2. Eur. Rev. Med. Pharmacol. Sci. 24, 893–904 (2020).
  21. Nielsen, J. B. et al. Genome-wide study of atrial fibrillation identifies seven risk loci and highlights biological pathways and regulatory elements involved in cardiac development. Am. J. Hum. Genet. 102, 103–115 (2018). · DOI · Paper page
  22. Voight, B. F. et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet 8, e1002793 (2012). · DOI · Paper page
  23. Parkes, M., Cortes, A., van Heel, D. A. & Brown, M. A. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat. Rev. Genet. 14, 661–673 (2013). · DOI · Paper page
  24. Sidore, C. et al. Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers. Nat. Genet. 47, 1272–1281 (2015). · DOI · Paper page
  25. Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinforma. Oxf. Engl. 26, 2190–2191 (2010). · DOI · Paper page
  26. Sudlow, C. et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015). · DOI · Paper page
  27. Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010). · DOI · Paper page
  28. Fan, Y. et al. Endothelial TFEB (Transcription Factor EB) positively regulates postischemic angiogenesis. Circ. Res. 122, 945–957 (2018). · DOI · Paper page
  29. Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013). · DOI · Paper page
  30. Li, H. et al. The sequence alignment/map format and SAMtools. Bioinforma. Oxf. Engl. 25, 2078–2079 (2009). · DOI · Paper page
  31. Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinforma. Oxf. Engl. 26, 841–842 (2010). · DOI · Paper page
  32. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinforma. Oxf. Engl. 26, 139–140 (2010). · DOI · Paper page
  33. Rom, O. et al. Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice. EBioMedicine 41, 62–72 (2019). · DOI
  34. Villacorta, L. et al. In situ generation, metabolism and immunomodulatory signaling actions of nitro-conjugated linoleic acid in a murine model of inflammation. Redox Biol. 15, 522–531 (2018). · DOI
  35. Kraehling, J. R. et al. Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells. Nat. Commun. 7, 13516 (2016). · DOI · Paper page
  36. Xiong, W. et al. Brown adipocyte-specific pparγ (peroxisome proliferator-activated receptor γ) deletion impairs perivascular adipose tissue development and enhances atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 38, 1738–1747 (2018). · DOI
  37. Collins, D. R. et al. Truncated variants of apolipoprotein B cause hypobetalipoproteinaemia. Nucleic Acids Res. 16, 8361–8375 (1988). · DOI · Paper page
  38. Chalasani, N., Vuppalanchi, R., Raikwar, N. S. & Deeg, M. A. Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study. J. Clin. Endocrinol. Metab. 91, 2279–2285 (2006). · DOI
  39. Haghpanah, S., Davani, M., Samadi, B., Ashrafi, A. & Karimi, M. Serum lipid profiles in patients with beta-thalassemia major and intermedia in southern Iran. J. Res. Med. Sci. J. Isfahan Univ. Med. Sci. 15, 150–154 (2010).
  40. Buonuomo, P. S. et al. Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride. J. Clin. Lipido. 11, 1329–1337.e3 (2017). · DOI

Cited by

See all 71

Metadata

Authors
Nielsen, J. B., Rom, O., Surakka, I., Graham, S. E., Zhou, W., Roychowdhury, T., Fritsche, L. G., Gagliano Taliun, S. A., Sidore, C., Liu, Y., Gabrielsen, M. E., Skogholt, A. H., Wolford, B., Overton, W., Zhao, Y., Chen, J., Zhang, H., Hornsby, W. E., Acheampong, A., Grooms, A., Schaefer, A., Zajac, G. J. M., Villacorta, L., Zhang, J., Brumpton, B., Løset, M., Rai, V., Lundegaard, P. R., Olesen, M. S., Taylor, K. D., Palmer, N. D., Chen, Y.-D., Choi, S. H., Lubitz, S. A., Ellinor, P. T., Barnes, K. C., Daya, M., Rafaels, N., Weiss, S. T., Lasky-Su, J., Tracy, R. P., Vasan, R. S., Cupples, L. A., Mathias, R. A., Yanek, L. R., Becker, L. C., Peyser, P. A., Bielak, L. F., Smith, J. A., Aslibekyan, S., Hidalgo, B. A., Arnett, D. K., Irvin, M. R., Wilson, J. G., Musani, S. K., Correa, A., Rich, S. S., Guo, X., Rotter, J. I., Konkle, B. A., Johnsen, J. M., Ashley-Koch, A. E., Telen, M. J., Sheehan, V. A., Blangero, J., Curran, J. E., Peralta, J. M., Montgomery, C., Sheu, W. H.-H., Chung, R.-H., Schwander, K., Nouraie, S. M., Gordeuk, V. R., Zhang, Y., Kooperberg, C., Reiner, A. P., Jackson, R. D., Bleecker, E. R., Meyers, D. A., Li, X., Das, S., Yu, K., LeFaive, J., Smith, A., Blackwell, T., Taliun, D., Zollner, S., Forer, L., Schoenherr, S., Fuchsberger, C., Pandit, A., Zawistowski, M., Kheterpal, S., Brummett, C. M., Natarajan, P., Schlessinger, D., Lee, S., Kang, H. M., Cucca, F., Holmen, O. L., Åsvold, B. O., Boehnke, M., Kathiresan, S., Abecasis, G. R., Chen, Y. E., Willer, C. J., & Hveem, K.
Venue
Nature Communications
Published
2020-12-18
Volume
11
Issue
1
Pages
6417-6417
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3113925949
Cited by
71
References
17
FWCI
8.77
Type
journal article
Language
en
Open access
gold
Licence
Funders
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R35-HL135824)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease. https://app.cochat.ai/papers/10.1038/s41467-020-20086-3
The paper
Nielsen, J. B., Rom, O., Surakka, I., Graham, S. E., Zhou, W., Roychowdhury, T., Fritsche, L. G., Gagliano Taliun, S. A., Sidore, C., Liu, Y., Gabrielsen, M. E., Skogholt, A. H., Wolford, B., Overton, W., Zhao, Y., Chen, J., Zhang, H., Hornsby, W. E., Acheampong, A., . . . Hveem, K. (2020). Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease. Nature Communications. https://doi.org/10.1038/s41467-020-20086-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.